To ensure safe, high-quality Advanced Therapy Medicinal Products (ATMPs) are delivered to patients, procurement activities must be standardized when possible. Standardization also supports efficiency and reduces the risk for error while meeting regulatory and accreditation requirements.
Download the UK Review and Recommendations on the Procurement of Starting Materials by Apheresis for ATMP Manufacture for insights into current mononuclear cell procurement practices in the ATMP community in the UK and recommendations on standardized approaches to reduce unnecessary complexity and variation.
Be The Match BioTherapies® Consultant Richard Smith participated in the working group and provided feedback on the document.